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ABSTRACT   
Background: Maternal smoking is currently a public health concern and has been associated 
with a number of complications in the offspring. E-cigarettes are gaining popularity as a ‘safer’ 
alternative to tobacco cigarettes during pregnancy, however, there are a limited number of 
studies to suggest that they are actually ‘safe’. 
Study Design: Balb/C female mice were exposed to ambient air (n=8; Sham), or tobacco 
cigarette smoke (n=8; SE) before gestation, during gestation and lactation. A third group was 
exposed to cigarette smoke before gestation followed by e-cigarette aerosols during gestation 
and lactation (n=8; Switch). Male offspring (12-week old, n=10-14/group) underwent 
behavioural assessments to investigate short-term memory, anxiety and activity using the novel 
object recognition (NOR) and elevated plus maze (EPM) tests. Brains were collected at 
postnatal day (P)1, P20 and Week13 for global DNA methylation, epigenetic gene expression, 
and neuronal cell counts. 
Results: The offspring from mothers switching to e-cigarettes exhibited no change in 
exploration/activity, but showed a decrease in global DNA methylation, Aurora Kinase (Aurk) 
A and AurkB gene expression and a reduction in neuronal cell numbers in the cornu ammonis 
1 region of the dorsal hippocampus compared to the SE group. 
Conclusions: Continuous tobacco cigarette smoke exposure during pregnancy resulted in 
marked neurological deficits in the offspring. Switching to e-cigarettes during pregnancy 
reduced these neurological deficits compared to cigarette smoke exposure. However, 
neurological changes were still observed, so we therefore conclude that e-cigarette use during 
pregnancy is not advised.  
 
INTRODUCTION 
Electronic cigarettes (e-cigarettes) are becoming increasingly popular worldwide and are 
attracting more users. E-cigarettes are battery-powered devices that convert an oily, flavoured 
liquid into an aerosol. Due to the variety of different flavours available, such as chocolate and 
cinnamon, e-cigarettes are particularly appealing to young people and they are gaining 
popularity among pregnant women, primarily as a smoking cessation aid or as a perceived 
healthier alternative to tobacco smoking (1, 2). 
 
Maternal exposure to tobacco cigarettes during pregnancy is associated with premature birth, 
low birth weight, cardiovascular problems, respiratory problems and sudden infant death 
syndrome (3-8). Moreover, children from mothers who smoked during their pregnancy exhibit 
behavioural changes such as hyperactivity, aggression and anti-social behaviour (9-11). 
According to the Centers for Disease Control and Prevention, in 2016, the prevalence of 
maternal smoking was highest among women aged between 20-24 (12). To assist these women 
to quit smoking, nicotine replacement therapies such as nicotine patches, gum and inhalers are 
available, however, many studies did not find a significant increase in abstinence (13-16). 
Therefore, there is a need to find new, innovative ways to assist pregnant women with their 
nicotine addiction. Although there is currently no evidence to prove that maternal ‘vaping’ is 
safe, pregnant women are starting to use e-cigarettes in higher numbers. A study of 445 
pregnant women in the United States in 2017 found that 7% of these women used e-cigarettes, 
and a further 8% were dual users of tobacco and e-cigarettes. Of the e-cigarette users, 74.6% 
reported that they switched to e-cigarettes once they had learnt that they were pregnant (2). 
Another review also suggested that the percentage of pregnant women who used an e-cigarette 
may be as high as 15% (17). Although they are promoted as a ‘safer’ alternative to smoking 
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tobacco cigarettes, studies in animals have shown that exposure to e-cigarette aerosols in adult 
male mice resulted in physiological and behavioural changes (18-20). 
 
We have previously reported the effects of maternal exposure to e-cigarette aerosols (with and 
without nicotine) on anxiety, exploration/activity and epigenetic gene expression in male 
offspring (21) and that replacing tobacco cigarette smoke with e-cigarette aerosols during 
pregnancy showed some benefits for energy homeostasis and inflammation in the offspring 
brain at weaning (22). The current study investigated whether switching to e-cigarette exposure 
from tobacco cigarette smoke during gestation, changes offspring behaviour and epigenetics.  
 
MATERIALS AND METHODS  
For the full materials and methods, please refer to the Supplementary document 1. 
Animal experiment procedure and treatment exposure 
All animal experimental procedures were conducted in accordance with the guidelines of the 
Australian National Health and Medical Research Council with approval from the University 
of Technology Sydney Animal Care and Ethics Committee (ETH15-0025). Twenty-four 
female Balb/c mice (7 weeks old, Animal Resource Centre, Perth, WA, Australia) had ad 
libitum food and water with a 12:12 hour light/dark light cycle.  
 
Animals were divided into three treatment groups (n=10-14 per group): (i) Ambient air (Sham); 
(ii) Tobacco cigarette smoke exposure (SE); and (iii) SE prior to gestation followed by e-
cigarette aerosol exposure during gestation and lactation (Switch). Animals from each 
treatment group were exposed to their condition six weeks prior to pregnancy, during 
pregnancy and lactation (Figure 1). Animals from the SE and Switch groups were exposed to 
two cigarettes twice daily (Winfield RedTM, ≤16mg tar, ≤1.2mg nicotine, and ≤15mg of CO; 
VIC, Australia) in an automated InExpose system (Scireq®, Montreal, QC, Canada). In the 
Switch group, animals were exposed to e-cigarette aerosols (Tobacco flavour; 18mg nicotine) 
using the KangerTech NEBOX e-cigarette device (KangerTech, Shenzhen, China). In the 
Switch group, animals were exposed to e-cigarette aerosols (Tobacco flavour; 18mg nicotine) 
using the KangerTech NEBOX e-cigarette device (KangerTech, Shenzhen, China) in 




Behavioural assessments were performed on offspring at 12 weeks old and all tests were 
performed between 0900 and 1400h. Each behavioural test was described in our previous study 
(21). The novel object recognition (NOR) test was used to assess short-term memory in the 
animals. The NOR test included a familiarisation and a test phase. The familiarisation phase 
involved an animal exploring two identical objects for 5 minutes before being returned to its 
home cage. After a one-hour interval, each animal underwent the test phase where they 
explored one ‘familiar’ object and one ‘novel’ object. The total time spent investigating each 







where Tn is the time spent exploring the novel object and Tf is the time spent exploring the 
familiar object. Unimpaired animals spend more time exploring the novel object compared to 




The elevated plus maze (EPM) test was used to measure anxiety and exploration. The EPM 
consists of an open arm and an enclosed arm. Each animal was placed on the EPM apparatus 
in the same direction to ensure consistency within each test. Animals were allowed to move 
freely on the EPM for two minutes before being returned into its home cage. The total time 
spent in the open arm and the number of centre crosses were recorded. In addition, the total 
number of head dips and whole body stretches in the close arm (protected) and the open arm 
(unprotected) were also recorded.  
 
 
Tissue collection and extraction 
Brain tissue and plasma were collected from offspring at P1 (birth), P20 (weaning) and Week13 
(adulthood) as previously described (21). Offspring were weighed before tissue collection. The 
right hemisphere of each P1 and P20 brain was snap frozen. The hippocampus was micro-
dissected from the right hemisphere from the Week13 offspring. Total DNA and RNA were 
extracted using the Isolate II DNA/RNA/protein extraction kit (Bioline, MA, USA) and 
quantified. RNA integrity was determined using the Experion RNA StdSens Analysis Kit 
(BioRad, CA, USA).  
 
Plasma cotinine 
Whole blood was collected in a heparin-rinsed syringe from mothers and offspring at P20 via 
cardiac puncture. Each plasma sample was collected by centrifuging the blood at 13k rpm for 
5 minutes. Plasma cotinine, a major metabolite of nicotine, was measured using the cotinine 
ELISA kit (Abnova, Taipei, Taiwan) following the manufacturer’s protocol. Samples and 
control standards (provided by the kit) were processed and the absorbance was read at 450nm 
using the Tecan’s Infinite® M1000 PRO (Thermo Fisher Scientific, MA, USA).  
 
Global 5-mC DNA methylation assay 
Global DNA methylation was analysed using the DNA 5-methylcytosine (5-mC) methylation 
ELISA kit (Zymo Research, CA, USA). DNA samples (100ng) from each offspring at P1, P20 
and Week 13 were processed according to the manufacturer’s protocol. Anti-5-methylcytosine 
monoclonal antibody was provided by the kit to detect 5-mC. DNA methylation of each DNA 
sample was quantified and expressed as a percentage using a standard curve generated by the 
control standards provided by the kit. Absorbance was read at 450nm using the Tecan’s 
Infinite® M1000 PRO (Thermo Fisher Scientific, MA, USA). 
 
Analysis of epigenetic mRNA gene expression levels 
Chromatin modifying mRNA gene expression levels were investigated using RT-qPCR. Total 
RNA (1µg) was extracted from P1 and P20 brains and Week13 hippocampus. RNA was 
reverse-transcribed using the Tetro cDNA synthesis kit (Bioline, MA, USA). qPCR 
amplification of cDNA was performed using the SensiFAST SYBR No-ROX kit (Bioline, MA, 
USA). All epigenetic primer sequences were listed in our previous study (21). mRNA gene 
expression was determined using the ∆∆Ct method (23) and normalization of mRNA gene 
expression was adjusted using glyceraldehyde 6-phosphate dehydrogenase (GAPDH) as the 
reference gene. 
 
Histological tissue preparation  
The left hemisphere of P20 and Week13 brains were fixed in 4% paraformaldehyde and 
paraffin embedded. Coronal sections (5µm) of the brains were made at Bregma; -1.9mm to -
2.06mm (24). The sections were stained with cresyl violet (Sigma Aldrich, MO, USA). High 
power images of the cornu ammonis (CA)1, CA2, CA3 at the dorsal hippocampus were 
5 
 
captured (NDP.view2, Hamamatsu, Shizuoka, Japan) and cell counts per region of interest 
(ROI) were completed using ImageJ (NIH, NY, USA). 
 
Statistical analysis 
All data analysis was conducted blindly and all data were presented as mean ± standard 
deviation. For the NOR test, a paired t-test was used to analyse the recognition index of the 
familiarisation and test phase. For the EPM test, the cotinine ELISA, the DNA methylation 
assay, and the mRNA gene expression, a one-way analysis of variance (ANOVA) with 
Bonferroni’s post-hoc test was used to compare each treatment group. A p-value of less than 
0.05 was considered statistically significant and the p value for Bonferroni post-hoc tests was 
reported in the text and figure legends to indicate differences between each group.  
 
RESULTS 
Maternal exposure to e-cigarette aerosols after smoke exposure did not have any effect 
on litter size  
There was no significant difference in litter size among the three groups (p=0.229) [data not 
shown]. Only male pups were used as per our previous study (21). There was no evidence of 
pups being born dead or cannibalised by the mothers. Sample sizes of offspring at each time 
point ranged between 10-14 depending on the size of the litter.  
 
Plasma cotinine levels from previous and current exposure systems delivered comparable 
levels of cotinine in the offspring and mothers 
The average cotinine level of the mothers from the Sham group was 2.95±0.93ng/ml. Mothers 
from the SE and Switch groups had a significant increase in plasma cotinine levels of 
19.36±10.17ng/ml (p<0.001) and 21.97±12.76ng/ml (p<0.01), respectively, compared to the 
Sham group (figure 2a). In the P20 offspring, the average cotinine level in the Sham group was 
3.56±1.60ng/ml. Offspring from the SE and Switch groups had a significant increase in 
cotinine levels of 9.62±3.66ng/ml (p<0.001) and 10.93±2.38ng/ml (p<0.001), respectively 
(figure 2b). 
 
Offspring from mothers that switched to e-cigarette aerosol exposure or exposed to 
continuous cigarette smoke during pregnancy had a low birth weight  
In the P1 offspring, the average body weight in the Sham group was 1.69±0.29g. Body weight 
in the SE and Switch groups were significantly reduced to 1.39±0.10g (p<0.05) and 1.41±0.12g 
(p<0.01), respectively, compared to the Sham group (figure 2c). In the P20 offspring, the 
average body weight in the Sham group was 10.63±1.41g. Body weight in the SE and Switch 
groups were significantly reduced to 9.45±0.58g (p<0.01) and 9.55±0.58g (p<0.001), 
respectively, compared to the Sham group (figure 2d). In the Week13 offspring, there was no 
significant difference in the body weight between the Sham (26.26±1.82g), SE (25.91±1.60g) 
and Switch groups (25.81±1.01g) (figure 2e). 
 
Switching to e-cigarette aerosol exposure showed changes in offspring memory and 
hyperactivity 
Behavioural assessments were conducted on Week12 offspring from each treatment group to 
determine if switching to e-cigarette alters offspring memory (NOR), exploration/activity 
(EPM) and anxiety (EPM) compared to SE. For the NOR test, in an unimpaired animal, there 
should be a significant increase in the recognition index from the familiarisation and test phase 
as shown in the Sham group (p<0.001;figure 3a). This result was also observed in the SE group 
(p<0.001;figure 3b). Interestingly, in the Switch group, there was no significant change 
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between the familiarisation and test phase, indicating short-term memory deficits within these 
offspring (figure 3c). 
 
In the EPM test, offspring showed a significant increase in the time spent in the open arm in 
the SE (p<0.001) and Switch groups (p<0.001) compared to the Sham group, indicating less 
anxiety (figure 3d). The number of centre crosses is an indication of exploration/activity. There 
was a significant increase in the number of centre crosses from SE (p<0.05) and Switch groups 
(p<0.05; figure 3e) compared to the Sham group. This indicates that offspring are more active 
and more likely to explore different environments. Other sensitive measures of anxiety such as 
head dipping and whole body stretches were not different. However, there was a significant 
increase in the number of unprotected stretches in offspring from the SE group compared to 
the Sham (p<0.001) and Switch groups (p<0.001; Supplementary figure 1). 
 
Switching to e-cigarette aerosol exposure reduced offspring global DNA methylation  
DNA methylation activates/inactivates genes by controlling the transfer of a methyl group on 
CpG sites of the genome (25). In the P1 offspring brain, global DNA methylation was 5.6±0.6% 
in the Sham group. DNA methylation in the SE and Switch groups were significantly increased 
to 44.3±5.7% (p<0.001) and 12.6±1.2% (p<0.01), respectively (figure 4a). In the P20 offspring 
brain, DNA methylation was 5.1±0.6% in the Sham group. DNA methylation in the SE and 
Switch groups were significantly increased to 39.0±3.6% (p<0.001) and 12.3±2.2% (p<0.001), 
respectively (figure 4b). In the Week13 hippocampus, DNA methylation was 9.5±1.1% in the 
Sham group. DNA methylation in the SE and Switch groups were significantly increased to 
40.8±3.2% (p<0.001) and 15.9±2.5% (p<0.001), respectively (figure 4c). Interestingly, despite 
the marked increase in global DNA methylation in both the SE and Switch groups, the Switch 
group showed a lower global DNA methylation when compared to the SE group, regardless of 
offspring age. Our findings suggest that switching to e-cigarettes during pregnancy reduced 
DNA methylation in the offspring brain. 
 
Changes in mRNA gene expression of key chromatin modifying genes in offspring from 
mothers that switched to e-cigarette aerosol exposure  
Epigenetic gene expression was analysed by RT-qPCR and outlined in Table 1. Here, we 
investigated epigenetic gene expression of representative chromatin modification enzymes that 
were identified and altered in our previous study (21).  
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Dnmt3a 1.0 ± 0.4 0.1 ± 0.1***† 0.6 ± 0.2 
Dnmt3b 1.0 ± 0.5 0.5 ± 0.1* 1.0 ± 0.3 
Kdm5c 1.0 ± 0.2 8.4 ± 3.2***††† 1.0 ± 0.4 
Kdm6b 1.0 ± 0.1 46.1 ± 30.1**†† 0.9 ± 0.3 
Atf2 1.0 ± 0.2 3.7 ± 0.9***††† 0.6 ± 0.2 
Hdac1 1.0 ± 0.1 2.6 ± 0.8**††† 0.8 ± 0.1 
Aurka 1.0 ± 0.2 1.4 ± 0.6 0.3 ± 0.0*### 
Aurkb 1.0 ± 0.1 2.9 ± 0.4***††† 0.4 ± 0.1*** 
















Dnmt3a 1.0 ± 0.1 0.6 ± 0.1 0.8 ± 0.3 
Dnmt3b 1.0 ± 0.3 0.7 ± 0.2 0.8 ± 0.4 
Kdm5c 1.0 ± 0.2 0.4 ± 0.1***††† 0.9 ± 0.3 
Kdm6b 1.0 ± 0.2 0.3 ± 0.1***††† 0.9 ± 0.3 
Atf2 1.0 ± 0.1 0.4 ± 0.1***††† 1.2 ± 0.3 
Hdac1 1.0 ± 0.1 1.3 ± 0.2* 1.1 ± 0.2 
Aurka 1.0 ± 0.2 0.4 ± 0.1**†† 1.0 ± 0.3 
Aurkb 1.0 ± 0.2 0.5 ± 0.1**††† 1.1 ± 0.3 













Dnmt3a 1.0 ± 0.1 0.6 ± 0.1**† 0.9 ± 0.3 
Dnmt3b 1.0 ± 0.2 0.2 ± 0.0***†† 0.7 ± 0.3 
Kdm5c 1.0 ± 0.2 1.5 ± 0.3 1.6 ± 0.6 
Kdm6b 1.0 ± 0.2 1.6 ± 0.3* 1.5 ± 0.5 
Atf2 1.0 ± 0.1 1.5 ± 0.2***††† 0.9 ± 0.1 
Hdac1 1.0 ± 0.1 1.3 ± 0.1**††† 0.9 ± 0.1 
Aurka 1.0 ± 0.1 1.2 ± 0.3†† 0.7 ± 0.2 
Aurkb 1.0 ± 0.2 1.4 ± 0.1*††† 0.6 ± 0.2** 
Aurkc 1.0 ± 0.4 0.3 ± 0.1* 0.9 ± 0.5 
The Sham, Smoke Exposure and Switch group data expressed as the percentage of gene 
expression normalised to the Sham group. Data is represented as mean ± standard deviation, 
*p<0.05, **p>0.01, ***p<0.001 vs. Sham, †p<0.05, ††p<0.01, †††p<0.001 vs. Switch, 
###p<0.001 vs. Smoke Exposure. 
 
DNA methyltransferases, Dnmt3a and Dnm3b, are de novo enzymes that are important in 
controlling the expression of certain genes in the genome. At P1, Dnmt3a and Dnmt3b gene 
expression was significantly decreased to 15.0±8.8% and 53.4±15.6%, respectively, in the SE 
group compared to the Sham (p<0.001) and Switch groups (p<0.05). In the P20 offspring whole 
brain, no significant difference was observed between treatment groups. In the Week13 
hippocampus, Dnmt3a and Dnmt3b gene expression was significantly decreased to 57.0±8.9% 
and 23.7±5.0%, respectively, in the SE group compared to the Sham (p<0.01) and the Switch 
groups (p<0.01). 
 
Histone demethylases, Kdm5c and Kdm6b, are important in the removal of methyl groups on 
histones. In the P1 offspring brain, Kdm5c gene expression was significantly increased to 
841.8±327.0% in the SE group compared to the Sham (p<0.001) and Switch groups (p<0.001). 
Similarly, Kdm6b gene expression was also significantly increased to 4609.4±3014.6% 
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compared to the Sham (p<0.001) and Switch groups (p<0.001). In the P20 offspring brain, 
Kdm5c gene expression was significantly decreased to 36.4±5.4% in the SE group compared 
to the Sham (p<0.001) and Switch groups (p<0.001). Similarly, Kdm6b gene expression was 
significantly decreased to 31.2±6.0% in the SE group compared to the Sham (p<0.001) and 
Switch groups (p<0.001). In the Week13 hippocampus, Kdm6b gene expression was 
significantly increased to 161.4±31.8% in the SE group compared to the Sham group (p<0.05). 
 
Histone acetylase, Atf2, and deacetylase, Hdac1, are important in adding and removing acetyl 
groups from histones. I the P1 offspring brain, Atf2 gene expression was significantly increased 
to 370.4±93.7% in the SE group compared to the Sham (p<0.001) and Switch groups 
(p<0.001). Similarly, Hdac1 gene expression was significantly increased to 256.8±80.2% in 
the SE group compared to the Sham (p<0.01) and Switch groups (p<0.001). In the P20 
offspring brain, Atf2 gene expression was significantly decreased to 36.2±5.9% in the SE group 
compared to the Sham (p<0.001) and Switch groups (p<0.001). In addition, Hdac1 gene 
expression was significantly increased to 131.2±18.1% in the SE group compared to the Sham 
group (p<0.05). In the Week13 offspring hippocampus, Atf2 gene expression was significantly 
increased to 152.9±17.2% in the SE group compared to the Sham (p<0.001) and Switch groups 
(p<0.001). Moreover, Hdac1 gene expression was significantly increased to 126.7±9.6% in the 
SE group compared to the Sham (p<0.01) and Switch groups (p<0.001). 
 
Aurora Kinases, AurkA, AurkB and AurkC, are important in chromosomal alignment and 
segregation during mitosis. In the P1 offspring brain, AurkA gene expression was significantly 
decreased to 31.7±4.4% in the Switch group compared to the Sham (p<0.05) and SE groups 
(p<0.001). AurkB gene expression was significantly increased to 295.7±36.2% in the SE group 
compared to the Sham (p<0.001) and Switch groups (p<0.001). However, AurkB gene 
expression was shown to be significantly decreased to 40.5±10.7% in the Switch group 
compared to the Sham group (p<0.001). No significant difference was observed in AurkC gene 
expression in any treatment groups. In the P20 offspring brain, AurkA gene expression was 
significantly decreased to 47.1±9.1% in the SE group compared to the Sham (p<0.01) and 
Switch groups (p<0.01). Similarly, AurkB gene expression was significantly decreased to 
49.8±14.4% in the SE group compared to the Sham (p<0.01) and Switch groups (p<0.001). 
AurkC gene expression was also significantly decreased to 51.1±10.4% in the SE group 
compared to the Switch group (p<0.05). In the Week13 offspring hippocampus, AurkA gene 
expression was significantly increased to 124.6±27.8% in the SE group compared to the Switch 
group (p<0.01). AurkB gene expression was significantly increased to 138.5±10.9% in the SE 
group compared to the Sham (p<0.05) and Switch groups (p<0.001). However, AurkB gene 
expression in the Switch group was significantly decreased to 55.5±22.9% compared to the 
Sham group (p<0.01). AurkC gene expression was significantly decreased to 34.4±10.9% in 
the SE group compared to the Sham group (p<0.05). 
 
Adult offspring from mothers exposed to tobacco smoke, but not e-cigarettes, have 
reduced neuronal counts in the hippocampus 
The dorsal hippocampus is a region of the brain that is important for cognitive functions such 
as learning and working memory. In the P20 offspring, the neuronal count at CA1 in the Sham 
group was at 170.43±8.83 cells/ROI (figure 5a). There was a significant reduction in neuronal 
counts in the SE and Switch groups at 154.42±4.16 cells/ROI (p<0.01) and 158±8.67 
neurons/ROI (p<0.05), respectively. At the CA2 and CA3 regions, no significant change in 
neuronal cell counts was observed in the offspring at P20 (figure 5b&c). In the Week13 
offspring, the neuronal cell count in the CA1, CA2, and CA3 in the Sham group was 
161.86±17.80, 100.00±8.74 and 123.00±14.73 cells/ROI, respectively. In the SE group, there 
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were marked reductions in the neuronal count at 143.00±10.56 cells/ROI (p<0.05) in CA1 
(figure 5d), 70.00±12.83 cells/ROI (p<0.001) in CA2 (figure 5e), and 103.25±8.65 cells/ROI 
(p<0.01) in CA3 (figure 5f). No significant difference in neuronal counts was observed in the 
hippocampus between Sham and Switch groups in the offspring at this time point. 
 
DISCUSSION 
We recently showed that the offspring from mice exposed to e-cigarette aerosols (with and 
without nicotine) during pregnancy had significant behavioural and epigenetic changes (21). 
In this study, we investigated whether maternal exposure to cigarette smoke (with nicotine) 
followed by a switch to e-cigarette aerosols (also with nicotine) changed the responses seen by 
continuous maternal smoking. 
 
The effects of maternal smoking on offspring body weight have been well-documented (5, 
26). We found a reduction in body weight from the smoke-exposed group, as expected. 
However, we showed that switching to e-cigarettes did not ameliorate this change in body 
weight in a murine model. By adulthood, however, all the offspring had returned to normal 
body weight and the drop in birth weight is likely due to a nicotine effect, as both the tobacco 
and the e-fluids contained nicotine in this study. A review of smokeless tobacco and nicotine 
replacement therapies also concluded that nicotine alone can reduce birth weight (27), 
however, another study examining nicotine replacement therapy has reported otherwise (28). 
In addition, elevated serum and urine cotinine levels have been shown to be closely 
correlated to the reduction in body weight following maternal exposure to cigarette smoke 
and e-cigarette aerosols (5, 18, 29-31).  
 
The experiments examining exploration/activity in offspring showed a similar pattern with 
both the maternal smoking and switching to e-cigarettes displaying increased activity and 
reduced anxiety. This is characteristic of hyperactivity which has been reported in human 
children from smoking mothers (32-36). The changes that we observed could be due to the 
nicotine exposure which has been shown to cause hyperactivity and impulse-decision making 
in offspring (30). A number of studies have investigated working memory in animals exposed 
to cigarette smoke and e-cigarette aerosols, with contradictory findings (37-39). These 
differences may be due to methodological factors such as differences in the dose and delivery 
of the cigarette compounds. We found that maternal smoking did not affect memory in the 
offspring compared to the Sham, whereas switching to e-cigarettes did. As both products 
contained nicotine, it could be concluded that the aerosol itself may be having an effect on 
memory in the offspring. 
 
Epigenetic changes often result in an alteration of the expression and regulation of genes that 
can play key roles during stages of normal development. Maternal smoking has been known to 
cause inter-generational alterations to DNA methylation in cord blood and the placenta (40, 
41). Our results showed that there were more marked changes in DNA methylation in offspring 
from mothers exposed to cigarette smoke only, which was reduced when switching to e-
cigarettes during pregnancy. However, this reduction in DNA methylation did not return to 
Sham levels. This suggests that chemical compounds that are found in cigarette smoke are 
likely to be the cause of these changes. Cigarette smoke consists of over 4000 known toxins 
such as arsenic, polychromatic hydrocarbons and acrolein which have shown to alter DNA 
methylation (42-44). E-cigarettes have also been known to release volatile organic compounds 
such as formaldehyde and tobacco-specific nitrosamines (45-47), however, the concentration 




DNA methylation can lead to changes in the expression of key genes that play a crucial role in 
development and cellular signalling and subsequently that may result in devastating 
consequences. In our previous study, we showed that mothers exposed to e-cigarette aerosol 
alone (with and without nicotine) resulted in changes to chromatin modifiers (21). These 
chromatin modifiers include DNA methyltransferases, histone demethylases, histone acetylase, 
histone deacetylase and Aurora Kinases. We showed that mothers exposed to e-cigarettes alone 
(with and without nicotine) had significant changes in Dnmt3a, Dnmt3b, Kdm5b, Kdm6b, 
Atf2, and Hdac1 gene expression in the offspring brain at birth, weaning and adulthood (21). 
In the current study, significant changes in gene expression were mainly observed in offspring 
from mothers exposed solely to cigarette smoke. However, gene expression of AurkA and 
AurkB, which are involved in mitotic division (50), were significantly decreased in in offspring 
from mothers switching to e-cigarette exposure, and significantly increased in offspring from 
mothers exposed to cigarette smoke only. This suggests that switching to e-cigarettes may alter 
epigenetic gene expression levels compared to continual smoke exposure, however, it can 
subsequently induce changes that are independent of smoking. It is likely that alterations to 
genes involved in generating epigenetic changes can result in physiological consequences, 
however, this remains to be investigated.  
 
The neuronal cell numbers in the dorsal hippocampus of the adult offspring were reduced in 
CA1 following maternal smoking, but there were no changes in this group in the NOR test. 
Conversely, offspring from mothers that switched to e-cigarette exposure after smoke exposure 
had an effect on memory, but not cell numbers. This highlights the difficulty of teasing out the 
effects of tobacco chemicals, nicotine and the chemicals in the e-fluids and how they may alter 
neurological function at different post-natal time-points. It is known that nicotine, when 
injected into pregnant rats, compromises offspring neuronal maturation, leading to long-lasting 
alterations in the structure of the hippocampus (51). A study that investigated the effects of 
prenatal nicotine exposure in a rat model found a decrease in cell size and a higher cell packing 
density in juvenile and adolescent offspring (52). Although many studies have shown that 
nicotine causes significant changes to regions of the hippocampus, there were no significant 
changes observed in the adult offspring for the Switch group in our study. Again, this may be 
due to the difference in nicotine delivery methods or possibly due to dose effects since previous 
studies have either administered nicotine orally through the water bottles or via a pump (52-
54). One study that investigated prenatal e-cigarette exposure in the offspring hippocampus 
found no changes to neuron numbers (55). However, they did find an increase in IBA-1 protein 
expression, a marker for microglia (55). This suggests that brain cells other than neurons can 
be affected by prenatal e-cigarette exposure.  
 
It is important to note that there are some limitations to the current study. The 5-mC DNA 
ELISA provides an overview of DNA methylation within the brain and does not show the 
specific genes that are methylated. Future experiments will be needed to focus on locating the 
genes that are methylated which will allow us to identify the physiological changes that are 
associated with those genes. Furthermore, a detailed analysis of the specific neuronal cell 
populations and different glial cells in the hippocampus and other brain regions would be 
beneficial to determine the cellular responses in the offspring.  
 
Overall, we conclude that in this murine model, lower levels of DNA methylation, lower levels 
of induced epigenetic modification of selected genes and no decrease in neuronal cell numbers 
were observed in the offspring of mothers that switched from tobacco cigarette smoke to e-
cigarette aerosol exposure, compared to those from mothers  continuously exposed to tobacco 
smoke during pregnancy. However, despite this, short-term memory deficits and hyperactivity 
11 
 
in the offspring were not affected by switching to e-cigarette during pregnancy. The results 
from this study, therefore, confirm that e-cigarette use during pregnancy is not a safe option. it 
may not be ‘safer’ to use than tobacco cigarette in terms of neurocognitive outcome, while the 
other physiological aspect remains to be determined. We conclude that abstinence from all 
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